z-logo
open-access-imgOpen Access
Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
Author(s) -
Jahit Sacarlal,
Pedro Aíde,
John J. Aponte,
Montse Renom,
Amanda Leach,
Inácio Mandomando,
Marc Lievens,
Quique Bassat,
Sarah Lafuente,
Eusébio Macete,
Johan Vekemans,
Caterina Guinovart,
Betuel Sigaúque,
Marla Sillman,
Jessica Milman,
MarieClaude Dubois,
MarieAnge Demoitié,
Joëlle Thonnard,
Clara Menéndez,
W. Ripley Ballou,
Joe Cohen,
Pedro L. Alonso
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/600119
Subject(s) - malaria , malaria vaccine , term (time) , medicine , virology , protozoal disease , immunology , environmental health , pediatrics , plasmodium falciparum , physics , quantum mechanics
We previously reported that the RTS,S/AS02A vaccine had an acceptable safety profile, was immunogenic, and demonstrated efficacy against Plasmodium falciparum malaria disease for 21 months.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom